Pipeline

Our Pipeline

Utilizing our RNP and ExRNA platforms, ExonanoRNA is developing a proprietary pipeline of RNA nanotechnology-based therapeutics for life-threatening late-stage oncology diseases. The advantage of RNA nanotechnology will have a transformative impact on improving cancer patients’ lives and reducing their suffering.

Even though our initial focus is on oncology diseases, we are also exploring the significant potential and versatility of RNA nanotechnology-based therapeutics in other disease areas.